Skip to main content
. Author manuscript; available in PMC: 2021 Jul 29.
Published in final edited form as: Am J Transplant. 2015 Mar 3;15(4):1014–1020. doi: 10.1111/ajt.13083

Table 1:

Titers of neutralizing antibodies to six different BKV genotypes in four different commercially available human immunoglobin preparations

Ia Ib2 Ic II III IV
IVIG #1 254,899.1 ± 1.1 14,918.1 ± 1.4 17,384.4 ± 1.6 18,368.5 ± 2.0 2,866.2 ± 1.3 3,359.0 ± 1.2
IVIG #2 75,791.1 ± 1.7 17,321.4 ± 1.2 41,026.7 ± 3.2 18,169.4 ± 1.2 8,345.0 ± 2.0 6,666.8 ± 1.9
CMVIG #1 157,370.0 ± 1.0 7,745.2 ± 1.5 15,827.3 ± 1.1 17,497.5 ± 1.4 1,893.4 ± 1.6 2,605.4 ± 1.1
CMVIG #2 33,067.8 ± 2.3 9,544.4 ± 1.3 13,333.2 ± 1.7 8,124.2 ± 1.3 5,628.3 ± 2.7 3,412.2 ± 1.87

Data represents geometric means ± SE of six experiments for each condition evaluated.